Avanos Medical, Inc.
Avanos Medical, Inc., headquartered in the United States, is a prominent player in the medical device industry, specialising in innovative solutions for pain management and surgical care. Founded in 2014, the company has rapidly established itself as a leader in its field, focusing on advanced technologies that enhance patient outcomes and streamline healthcare processes. With a diverse portfolio that includes products for pain management, wound care, and respiratory health, Avanos Medical distinguishes itself through its commitment to quality and innovation. The company operates in key regions across North America and Europe, ensuring a broad reach in delivering its unique offerings. Notable achievements include significant advancements in regional anaesthesia and the development of proprietary devices that improve procedural efficiency. Avanos Medical continues to solidify its market position by prioritising patient-centric solutions and fostering strong partnerships within the healthcare community.
DitchCarbon Score
How does Avanos Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Avanos Medical, Inc.'s score of 32 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Avanos Medical, Inc.'s reported carbon emissions
In 2024, Avanos Medical, Inc. reported total carbon emissions of approximately 14,112,150 kg CO2e. This figure includes about 1,458,070 kg CO2e from Scope 1 emissions and approximately 12,654,080 kg CO2e from Scope 2 emissions. In the previous year, 2023, the company’s total emissions were about 14,457,820 kg CO2e, with Scope 1 emissions at approximately 1,786,730 kg CO2e and Scope 2 emissions at around 12,671,090 kg CO2e. Despite these figures, Avanos has not set specific reduction targets or initiatives as part of their climate commitments. There are no reported commitments to the Science Based Targets initiative (SBTi) or other climate pledges. The company’s emissions data is not cascaded from any parent organisation, indicating that these figures are solely from Avanos Medical, Inc. Overall, while Avanos Medical, Inc. has made strides in tracking its carbon emissions, it currently lacks defined reduction strategies or targets to mitigate its environmental impact.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 1,786,730 | 0,000,000 |
| Scope 2 | 12,671,090 | 00,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Avanos Medical, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
